Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.22.2.2
Stock-Based Compensation - TripCo Outstanding Awards (Details) - 2019 Plan - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
9 Months Ended
Sep. 30, 2022
Additional disclosures  
Unvested value not yet recognized $ 4.2
Weighted average period the unrecognized compensation cost will be recognized 2 years 1 month 6 days
Amount of share reserve 3,500
Stock Options | Series A  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding beginning balance 1,129
Outstanding ending balance 1,129
Options exercisable 534
WAEP  
Weighted average exercise price, options outstanding (in dollars per share) $ 7.20
Weighted average exercise price, options outstanding (in dollars per share) 7.20
Weighted average exercise price, options exercisable (in dollars per share) $ 10.33
Weighted average remaining contractual term outstanding 4 years 3 months 18 days
Weighted average remaining contractual term exercisable 3 years 4 months 24 days
Stock Options | Series B  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding beginning balance 2,397
Outstanding ending balance 2,397
Options exercisable 2,397
WAEP  
Weighted average exercise price, options outstanding (in dollars per share) $ 21.93
Weighted average exercise price, options outstanding (in dollars per share) 21.93
Weighted average exercise price, options exercisable (in dollars per share) $ 21.93
Weighted average remaining contractual term outstanding 3 years
Weighted average remaining contractual term exercisable 3 years
Outstanding, aggregate intrinsic value $ 18.0
Exercisable, aggregate intrinsic value $ 18.0
Performance Based RSUs | Series B | CEO  
Additional disclosures  
RSUs granted 367
Weighted average grant date fair value, RSUs and MSUs granted (in dollars per share) $ 2.04
Vesting period 1 year